Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

286 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Total escape of SARS-CoV-2 from dual monoclonal antibody therapy in an immunocompromised patient.
Jaki L, Weigang S, Kern L, Kramme S, Wrobel AG, Grawitz AB, Nawrath P, Martin SR, Dähne T, Beer J, Disch M, Kolb P, Gutbrod L, Reuter S, Warnatz K, Schwemmle M, Gamblin SJ, Neumann-Haefelin E, Schnepf D, Welte T, Kochs G, Huzly D, Panning M, Fuchs J. Jaki L, et al. Among authors: warnatz k. Nat Commun. 2023 Apr 10;14(1):1999. doi: 10.1038/s41467-023-37591-w. Nat Commun. 2023. PMID: 37037847 Free PMC article.
Active vaccination in patients with common variable immunodeficiency (CVID).
Goldacker S, Draeger R, Warnatz K, Huzly D, Salzer U, Thiel J, Eibel H, Schlesier M, Peter HH. Goldacker S, et al. Among authors: warnatz k. Clin Immunol. 2007 Sep;124(3):294-303. doi: 10.1016/j.clim.2007.04.011. Epub 2007 Jun 29. Clin Immunol. 2007. PMID: 17602874 Clinical Trial.
Rubella vaccine-induced granulomas are a novel phenotype with incomplete penetrance of genetic defects in cytotoxicity.
Groß M, Speckmann C, May A, Gajardo-Carrasco T, Wustrau K, Maier SL, Panning M, Huzly D, Agaimy A, Bryceson YT, Choo S, Chow CW, Dückers G, Fasth A, Fraitag S, Gräwe K, Haxelmans S, Holzinger D, Hudowenz O, Hübschen JM, Khurana C, Kienle K, Klifa R, Korn K, Kutzner H, Lämmermann T, Ledig S, Lipsker D, Meeths M, Naumann-Bartsch N, Rascon J, Schänzer A, Seidl M, Tesi B, Vauloup-Fellous C, Vollmer-Kary B, Warnatz K, Wehr C, Neven B, Vargas P, Sepulveda FE, Lehmberg K, Schmitt-Graeff A, Ehl S. Groß M, et al. Among authors: warnatz k. J Allergy Clin Immunol. 2022 Jan;149(1):388-399.e4. doi: 10.1016/j.jaci.2021.05.007. Epub 2021 May 24. J Allergy Clin Immunol. 2022. PMID: 34033843
Case Series: Convalescent Plasma Therapy for Patients with COVID-19 and Primary Antibody Deficiency.
Lang-Meli J, Fuchs J, Mathé P, Ho HE, Kern L, Jaki L, Rusignuolo G, Mertins S, Somogyi V, Neumann-Haefelin C, Trinkmann F, Müller M, Thimme R, Umhau M, Quinti I, Wagner D, Panning M, Cunningham-Rundles C, Laubner K, Warnatz K. Lang-Meli J, et al. Among authors: warnatz k. J Clin Immunol. 2022 Feb;42(2):253-265. doi: 10.1007/s10875-021-01193-2. Epub 2021 Dec 10. J Clin Immunol. 2022. PMID: 34893946 Free PMC article.
Mechanisms of CD8+ T-cell failure in chronic hepatitis E virus infection.
Kemming J, Gundlach S, Panning M, Huzly D, Huang J, Lütgehetmann M, Pischke S, Schulze Zur Wiesch J, Emmerich F, Llewellyn-Lacey S, Price DA, Tanriver Y, Warnatz K, Boettler T, Thimme R, Hofmann M, Fischer N, Neumann-Haefelin C. Kemming J, et al. Among authors: warnatz k. J Hepatol. 2022 Oct;77(4):978-990. doi: 10.1016/j.jhep.2022.05.019. Epub 2022 May 28. J Hepatol. 2022. PMID: 35636577 Free article.
Passive immunization against COVID-19 by anti-SARS-CoV-2 spike IgG in commercially available immunoglobulin preparations in severe antibody deficiency.
Hirsiger JR, Weigang S, Walz AC, Fuchs J, Daly ML, Eggimann S, Hausmann O, Schwemmle M, Kochs G, Panning M, Warnatz K, Recher M, Berger CT. Hirsiger JR, et al. Among authors: warnatz k. J Allergy Clin Immunol Pract. 2022 Sep;10(9):2452-2455.e3. doi: 10.1016/j.jaip.2022.06.020. Epub 2022 Jun 29. J Allergy Clin Immunol Pract. 2022. PMID: 35779780 Free PMC article. No abstract available.
Age-associated B cells predict impaired humoral immunity after COVID-19 vaccination in patients receiving immune checkpoint blockade.
Yam-Puc JC, Hosseini Z, Horner EC, Gerber PP, Beristain-Covarrubias N, Hughes R, Lulla A, Rust M, Boston R, Ali M, Fischer K, Simmons-Rosello E, O'Reilly M, Robson H, Booth LH, Kahanawita L, Correa-Noguera A, Favara D, Ceron-Gutierrez L, Keller B, Craxton A, Anderson GSF, Sun XM, Elmer A, Saunders C, Bermperi A, Jose S, Kingston N, Mulroney TE, Piñon LPG; CITIID-NIHR COVID−19 BioResource Collaboration; Chapman MA, Grigoriadou S, MacFarlane M, Willis AE, Patil KR, Spencer S, Staples E, Warnatz K, Buckland MS, Hollfelder F, Hyvönen M, Döffinger R, Parkinson C, Lear S, Matheson NJ, Thaventhiran JED. Yam-Puc JC, et al. Among authors: warnatz k. Nat Commun. 2023 Jun 27;14(1):3292. doi: 10.1038/s41467-023-38810-0. Nat Commun. 2023. PMID: 37369658 Free PMC article.
COVID-19 progression and convalescence in common variable immunodeficiency patients show dysregulated adaptive immune responses and persistent type I interferon and inflammasome activation.
Rodríguez-Ubreva J, Calafell-Segura J, Calvillo CL, Keller B, Ciudad L, Handfield LF, de la Calle-Fabregat C, Godoy-Tena G, Andrés-León E, Hoo R, Porter T, Prigmore E, Hofmann M, Decker A, Martín J, Vento-Tormo R, Warnatz K, Ballestar E. Rodríguez-Ubreva J, et al. Among authors: warnatz k. Nat Commun. 2024 Nov 28;15(1):10344. doi: 10.1038/s41467-024-54732-x. Nat Commun. 2024. PMID: 39609471 Free PMC article.
286 results